Magdalena Plebanski

Professor

RMIT University

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Magdalena Plebanski is a Professor at RMIT University in Australia. Her research focuses on cancer immunotherapies, particularly the role of interleukin-6 in ovarian cancer, and she has contributed significantly to studies in malaria vaccine development and diagnostic biomarkers for cancer. Recent publications highlight her expertise in immune modulation and the application of innovative therapeutic strategies in oncology.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (21)

FRANCESCA CAVALIERI

Associate Professor

Università degli Studi di Roma La Sapienza

ITALY

Magdalena Plebanski

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

IGSF11-Mediated Immune Modulation: Unlocking a Novel Pathway in Emerging Cancer Immunotherapies

Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities

Recent perspectives in clinical development of malaria vaccines

Dead in the water – Role of relic DNA and primer choice for targeted sequencing surveys of anaerobic sewage sludge intended for biological monitoring

Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial

Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis

Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies

Cholesterol as an inbuilt immunoadjuvant for a lipopeptide vaccine against group A Streptococcus infection

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses

The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines

Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape

Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts.

A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer

A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.

Higher Adherence to a Mediterranean Diet Is Associated with Improved Insulin Sensitivity and Selected Markers of Inflammation in Individuals Who Are Overweight and Obese without Diabetes

Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker

Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system.

Influence of protein corona on the interaction of glycogen–siRNA constructs with ex vivo human blood immune cells

Collaborators (21)

FRANCESCA CAVALIERI

Georgia Goodchild

David Scott

David A. Foley

Robert J. Capon

Ben van den Akker

Apriliana E. R. Kartikasari

Srinivasa Reddy Telukutla

Maximilian de Courten

Jakub Mesinovic

Jennifer Boer

Christopher Numa Lemoh

Aya Mousa

Daniel Dias

Waleed M. Hussein

Mariusz Skwarczynski

Jack Feehan

Richard Stuetz

Vasso Apostolopoulos

Jessica Holien

J Frič

Make your next move.